SFA Therapeutics
Latest round
- Seed
Last raised
- Jun 2022
Total raised
- $4M
Investors
- 8
About SFA Therapeutics
SFA Therapeutics, Inc.Founded in 2016 and headquartered in Jenkintown, US, SFA Therapeutics specializes in biosynthetic compound development.00 mn.SFA Therapeutics specializes in developing innovative biosynthetic compounds aimed at treating a variety of health challenges, including autoimmune diseases, cancers, infectious diseases, and liver diseases. Their core product offerings leverage a unique platform technology that focuses on the selective targeting of disease-specific pathways, allowing for the creation of drugs that mimic naturally occurring substances within the human body. These biosynthetic molecules, designed to enhance immune function and modulate inflammatory responses, are particularly relevant for conditions such as psoriasis, rheumatoid arthritis, hepatocellular carcinoma, and post-viral inflammatory complications.SFA Therapeutics operates a revenue model that includes direct partnerships with healthcare institutions and pharmaceutical companies for the development and commercialization of its biosynthetic therapies. The company engages in B2B transactions, focusing on collaborations that allow for the integration of their products into clinical treatment protocols. Revenue generation is anticipated through licensing agreements and the provision of specialized formulations for clinical trials, with a focus on flagship products like SFA-002, which is currently undergoing clinical trials for psoriasis treatment. The company is looking to expand its market presence by targeting specific regions in North America and Europe for broader distribution of its biosynthetic therapies. Upcoming product launches and further clinical trials are expected to enhance its therapeutic offerings.
Who invested in SFA Therapeutics
8 investors across 1 round
See all investors in SFA Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jun 20, 2022
Amount
$4M
Investors
Questions about SFA Therapeutics
Who invested in SFA Therapeutics?
SFA Therapeutics has 8 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SFA Therapeutics raised?
SFA Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did SFA Therapeutics last raise money?
SFA Therapeutics's most recent round on record is a Seed, in Jun 2022.
What does SFA Therapeutics do?
SFA Therapeutics is a biotechnology company.
Where is SFA Therapeutics headquartered?
SFA Therapeutics is headquartered in Jenkintown, US.
Which VCs invest in companies like SFA Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at SFA Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like SFA Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.